FSK vs CNS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 24, 2026

FSK

51.0
AI Score
VS
CNS Wins

CNS

56.1
AI Score

Investment Advisor Scores

FSK

51score
Recommendation
STRONG BUY

CNS

56score
Recommendation
BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric FSK CNS Winner
Forward P/E 7.9239 18.4502 FSK
PEG Ratio 3.2724 1.6881 CNS
Revenue Growth -27.1% 11.1% CNS
Earnings Growth 33.8% 0.0% FSK
Tradestie Score 51.0/100 56.1/100 CNS
Profit Margin -28.5% 28.2% CNS
Beta 1.00 1.00 Tie
AI Recommendation STRONG BUY BUY FSK

Relative Price Performance (Last 90 Days)

FSK 1M: -6.5% · 3M: -3.8% CNS 1M: -5.5% · 3M: -12.4%

Current Technical Phase

FSK

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.0%), weak momentum, RSI 40

RSI (14): 39.9 · Price: $10.44

CNS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 47

RSI (14): 46.8 · Price: $71.00

Fundamentals Snapshot

Metric FSK CNS
Market Cap — —
Forward P/E 7.0 19.0
Trailing P/E — 21.6
Revenue (TTM) — —
Revenue Growth -0.3% 0.1%
Gross Margin 1.0% 0.5%
Operating Margin 0.7% 0.3%
EPS -1.41 3.33
Dividend Yield 0.21% 0.04%

Frequently Asked Questions

Based on our detailed analysis, CNS is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.